Last reviewed · How we verify
NCT05209828
Post-market Clinical Follow-up of Pfmmedical Ports
trial testing pfmmedical implantable vascular access ports in Vascular Access Port in 149 participants. Completed in 9 March 2023.
9 March 2023
Quick facts
| Lead sponsor | pfm medical gmbh |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 149 |
| Start date | 13 April 2022 |
| Primary completion | 9 March 2023 |
| Estimated completion | 9 March 2023 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- pfmmedical implantable vascular access ports
Conditions studied
- Vascular Access Port — all drugs for Vascular Access Port →
- Patient Satisfaction — all drugs for Patient Satisfaction →
Sponsor
pfm medical gmbh
Who can join
18 and older, any sex, with Vascular Access Port or Patient Satisfaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective, monocentric, non-randomised, observational post-market clinical follow-up study in Germany to obtain post-market information on the pfmmedical ports with a follow-up (FU) of 6 months. The focus is on patient reported satisfaction, clinical application, and complication rates.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prospective, monocentric observational study on the clinical use and patient satisfaction of an implantable venous access Port.
Werba A, Hennes R, Schuh F, Holze M, et al · · 2025 · cited 1× · PMID 40009241 · DOI 10.1007/s00423-025-03654-3
Verify or expand the search:
- PubMed search for NCT05209828
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other pfm medical gmbh trials
Trials by the same sponsor.
- NCT03868514 — Post Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket) · completed
- NCT02690220 — Anterior Pelvic Prolapse Reconstruction With TiLOOP® PRO A Polypropylene Mesh · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05209828 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by pfm medical gmbh
- Last refreshed: 5 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05209828.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing